Last summer, a young man walked into our clinic determined to stop his methadone. He had been stable for months, working, reconnecting with family, until a viral video convinced him that methadone was “poison,” part of a government plot to keep people addicted. He told me, “Doc, I think I’m ready to do this on my own.” Two weeks later, he overdosed.

At the Yale School of Medicine, we’re trained to interpret data, not defend it. Yet in 2025, defending the truth has become part of the job.

Across the country, medicine faces a new epidemic: misinformation. From vaccines to addiction treatment, science itself has become politicized. Earlier this year, the National Institutes of Health paused a major study on health misinformation after political pushback, raising concerns about interference in public health research. The NIH has proposed cutting university research overhead, a move that would drain resources from community programs.The ground under evidence keeps shifting.

Here at Yale, those national tremors become local realities. At the Yale Program in Addiction Medicine, we meet people every week whose lives are threatened not only by fentanyl but by falsehoods. Misinformation can turn a lifesaving medication into a moral battleground. Patients fear that buprenorphine is “replacing one addiction with another” or that naloxone, the overdose-reversal medication, “causes overdoses.” These myths spread faster than methadone can stabilize.

Yale’s Community Health Care Van, a mobile harm-reduction unit that travels through New Haven, offers clean syringes, HIV testing and linkage to care. Yet its staff often spend hours countering online rumors instead of treating patients. In August, Connecticut addiction advocates released a short film, “The Truth About Fentanyl Exposure,” to debunk claims that merely touching fentanyl can cause an overdose, a myth still believed by many in our own community. This isn’t abstract misinformation; it’s misinformation that kills.

The erosion of trust also affects how care is delivered. A 2022 survey by the Yale Global Health Justice Partnership found that nearly one-third of Connecticut respondents viewed misinformation about fentanyl exposure and treatment as a major problem in local media coverage. Yale researchers recently reported in JAMA Network Open that racial and ethnic disparities persist in those who receive addiction treatment after an emergency department visit, disparities that deepen when misinformation discourages people from seeking help. When institutions lose credibility, science loses reach.

Meanwhile, the policy environment grows murkier. Federal scrutiny of addiction-research grants has made universities cautious. The CDC’s evolving recommendations on opioids have left both patients and providers uncertain about what “safe prescribing” even means. For a patient deciding whether to trust a medication, or a physician deciding whether to initiate it, ambiguity feels like betrayal.

Yale stands at the intersection of these tensions. The University partners with the Connecticut Department of Mental Health and Addiction Services and helps guide the state’s opioid response Initiative, which deploys settlement funds for prevention and harm reduction. But the success of those programs depends on public confidence. When misinformation spreads faster than outreach, even well-funded interventions lose their footing.

The challenge now isn’t data; it’s delivery. Medical education still treats communication as a “soft skill” when it should be a survival skill. We need to train physicians to engage publicly with humility, to translate complexity without dilution and to counter falsehoods without arrogance.

Yale is uniquely positioned to lead that change. Its programs, from the Global Health Justice Partnership to the Community Health Care Van, already bridge research and community. The next step is institutional: valuing public communication as seriously as publication. That means supporting physicians who write, speak and post responsibly in public spaces and protecting them from the backlash that often follows.

The next frontier of medicine isn’t technological. It’s relational. It’s about rebuilding credibility in an age when anyone with a smartphone can drown out an epidemiologist. If we don’t equip future physicians to meet people where they are — their feeds, their fears, their forums — we’ll keep winning scientific battles while losing public trust. 

The path forward begins in how we teach. Medical training should prepare students not only to diagnose disease but to recognize and respond to the spread of misinformation , an epidemic of its own. Integrating media literacy and science-communication skills into medical curricula is not an academic luxury; it’s a public-health necessity.

Yale’s motto is a promise as much as a legacy. Lux et Veritas can’t remain carved in stone; it must be lived out loud in classrooms, clinics and communities. Because if institutions built on truth don’t defend it, someone else, less qualified, less honest and far more viral will. The stethoscope and the pen once defined the physician. Today, it may also be the microphone.

JOHN FOMECHE is an Addiction Medicine Fellow at the Yale School of Medicine. He can be reached at john.fomeche@yale.edu.